Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Parallel-Controlled, Blinded-Assessment, Non-Inferiority Clinical Trial to Evaluate the Safety and Effectiveness of a Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars

NCT07620769 is registered in ClinicalTrials.gov with CLASSYS Inc. as lead sponsor.

NCT NCT07620769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Parallel-Controlled, Blinded-Assessment, Non-Inferiority Clinical Trial to Evaluate the Safety and Effectiveness of a Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars
Lead sponsor
CLASSYS Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
October 31, 2027
Enrollment
252 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acne scar, acne scarring, acne scars, acne scars - atrophic